EUROPE’S MEETING PLACE FOR THE RARE DISEASE COMMUNITY. The 8th annual World Orphan Drug Congress is the marketplace for orphan drug professionals looking at the complete value chain of orphan drug development, from clinical development and R&D to corporate development and market access. George is chairing an interactive roundtable "Linking registries and clinical trials through ERNs: The paradigm shift in meeting Marketing Authorization requirements" @ 11.20 on November 15th